SCOPUS 정보 검색 플랫폼

Cancer Chemotherapy and Pharmacology

Volumn 50, Issue 3, 2002, Pages 251-255

Extremely high exposures in an obese patient receiving high-dose cyclophosphamide, thiotepa and carboplatin

(5) De Jonge, Milly E a Mathôt, Ron A a Van Dam, Selma M a Beijnen, Jos H a Rodenhuis, Sjoerd b

a SLOTERVAART HOSPITAL (Netherlands)

b NETHERLANDS CANCER INSTITUTE (Netherlands)

Author keywords

Carboplatin; Cyclophosphamide; Dosage; Obese; Thiotepa

Indexed keywords

4 HYDROXYCYCLOPHOSPHAMIDE; CARBOPLATIN; CREATININE; CYCLOPHOSPHAMIDE; PLATINUM DERIVATIVE; THIOTEPA;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BODY SURFACE; BODY WEIGHT; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CASE REPORT; CONTROLLED STUDY; CREATININE CLEARANCE; DOSE CALCULATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MEGADOSE; DRUG MONITORING; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AREA UNDER CURVE; BREAST NEOPLASMS; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MIDDLE AGED; MODELS, THEORETICAL; OBESITY; THIOTEPA;

EID: 0036042732 PISSN: 03445704 EISSN: None Source Type: Journal
DOI: 10.1007/s00280-002-0494-7 Document Type: Article

Times cited : (37)

References (25)

1
- 0026748897
- Cyclophosphamide pharmacokinetics: Correlation with cardiac toxicity and tumor response
- (1992) J Clin Oncol , vol.10 , pp. 995
- Ayash, L.J.¹ Wright, J.E.² Tretyakov, O.³ Gonin, R.⁴ Elias, A.⁵ Wheeler, C.⁶ Eder, J.P.⁷ Rosowsky, A.⁸ Antman, K.⁹ Frei E. III¹⁰

2
- 0003747347
- University of California at San Francisco, San Francisco
- (1998) User's guides, NONMEM Project Group
- Beal, S.L.¹ Sheiner, L.B.²

3
- 0031155476
- How to predict carboplatin clearance from standard morphological and biological characteristics in obese patients
- (1997) Ann Oncol , vol.8 , pp. 607
- Bénézet, S.¹ Guimbaud, R.² Chatelut, E.³ Chevreau, C.⁴ Bugat, R.⁵ Canal, P.⁶

4
- 0024440650
- Carboplatin dosage: Prospective evaluation of a simple formula based on renal function
- (1989) J Clin Oncol , vol.7 , pp. 1748
- Calvert, A.H.¹ Newell, D.R.² Gumbrell, L.A.³ O'Reilly, S.⁴ Burnell, M.⁵ Boxall, F.E.⁶ Siddik, Z.H.⁷ Judson, I.R.⁸ Gore, M.E.⁹ Wiltshaw, E.¹⁰

5
- 0028936713
- Prediction of carboplatin clearance from standard morphological and biological patient characteristics
- (1995) J Natl Cancer Inst , vol.87 , pp. 573
- Chatelut, E.¹ Canal, P.² Brunner, V.³ Chevreau, C.⁴ Pujol, A.⁵ Boneu, A.⁶ Roché, H.⁷ Houin, G.⁸ Bugat, R.⁹

6
- 0027223897
- Clinical pharmacokinetics of drugs in obesity. An update
- (1993) Clin Pharmacokinet , vol.25 , pp. 103
- Cheymol, G.¹

7
- 0016916438
- Prediction of creatinine clearance from serum creatinine
- (1976) Nephron , vol.16 , pp. 31
- Cockcroft, D.W.¹ Gault, M.H.²

8
- 33744839368
- A formula to estimate the approximate surface area if height and weight be known
- (1916) Arch Intern Med , vol.17 , pp. 863
- DuBois, D.¹ DuBois, E.²

9
- 0036018898
- Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thioTEPA and carboplatin
- (2002) Ann Oncol , vol.13 , pp. 374
- Huitema, A.D.¹ Spaander, M.² Mathôt, R.A.³ Tibben, M.M.⁴ Holtkamp, M.J.⁵ Beijnen, J.H.⁶ Rodenhuis, S.⁷

10
- 0029874346
- A phase I/II study of high-dose cyclophosphamide, cisplatin, and thiotepa followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignancies
- (1996) Cancer Chemother Pharmacol , vol.37 , pp. 561
- Hussein, A.M.¹ Petros, W.P.² Ross, M.³ Vredenburgh, J.J.⁴ Affronti, M.L.⁵ Jones, R.B.⁶ Shpall, E.J.⁷ Rubin, P.⁸ Elkordy, M.⁹ Gilbert, C.¹⁰ Gupton, C.¹¹ Egorin, M.J.¹² Soper, J.¹³ Berchuck, A.¹⁴ Clarke-Pearson, D.¹⁵ Berry, D.A.¹⁶ Peters, W.P.¹⁷

11
- 0026100542
- Clinical pharmacokinetics of cyclophosphamide
- (1991) Clin Pharmacokinet , vol.20 , pp. 194
- Moore, M.J.¹

12
- 0003262235
- Correlation of high-dose cyclophosphamide, cisplatin, and carmustine pharmacokinetics to response and toxicity in patients with primary breast cancer
- (1997) Proc ASCO , vol.16
- Petros, W.P.¹ Broadwater, G.² Berry, D.³ Jones, R.B.⁴ Vredenburgh, J.J.⁵ Gilbert, C.J.⁶ Colvin, O.M.⁷ Peters, W.P.⁸

13
- 0023270126
- Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients
- (1987) Cancer Chemother Pharmacol , vol.20 , pp. 219
- Powis, G.¹ Reece, P.² Ahmann, D.L.³ Ingle, J.N.⁴

14
- 0028839172
- Dosing of thiotepa for myeloablative therapy
- (1995) Cancer Chemother Pharmacol , vol.37 , pp. 155
- Przepiorka, D.¹ Madden, T.² Ippoliti, C.³ Estrov, Z.⁴ Dimopoulos, M.⁵

15
- 0026618928
- Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantation incorporating carboplatin, cyclophosphamide and thiotepa
- (1992) Ann Oncol , vol.3 , pp. 855
- Rodenhuis, S.¹ Baars, J.W.² Schornagel, J.H.³ Vlasveld, L.T.⁴ Mandjes, I.⁵ Pinedo, H.M.⁶ Richel, D.J.⁷

16
- 0029978783
- Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancer
- (1996) J Clin Oncol , vol.14 , pp. 1473
- Rodenhuis, S.¹ Westermann, A.² Holtkamp, M.J.³ Nooijen, W.J.⁴ Baars, J.W.⁵ Van der Wall, E.⁶ Slaper-Cortenbach, C.M.⁷ Schornagel, J.H.⁸

17
- 7344254625
- Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement
- (1998) Lancet , vol.352 , pp. 515
- Rodenhuis, S.¹ Richel, D.J.² Van der Wall, E.³ Schornagel, J.H.⁴ Baars, J.W.⁵ Koning, C.C.E.⁶ Peterse, J.L.⁷ Borger, J.H.⁸ Nooijen, W.J.⁹ Bakx, R.¹⁰ Dalesio, O.¹¹ Rutgers, E.¹²

18
- 0033374916
- A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remission
- (1999) Ann Oncol , vol.10 , pp. 1467
- Rodenhuis, S.¹ De Wit, R.² De Mulder, P.H.M.³ Keizer, H.J.⁴ Sleijfer, D.T.⁵ Lalisang, R.I.⁶ Bakker, P.J.M.⁷ Mandjes, I.⁸ Kooi, M.⁹ De Vries, E.G.E.¹⁰

19
- 0023943265
- Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass
- (1998) Am J Med , vol.84 , pp. 1053
- Salazar, D.E.¹ Corcoran, G.B.²

20
- 0035015115
- Body surface area as a determinant of pharmacokinetics and drug dosing
- (2001) Invest New Drugs , vol.19 , pp. 171
- Sawyer, M.¹ Ratain, M.J.²

21
- 0028808871
- Accuracy of estimated creatinine clearance in obese patients with stable renal function in the intensive care unit
- (1995) Pharmacotherapy , vol.15 , pp. 747
- Snider, R.D.¹ Kruse, J.A.² Bander, J.J.³ Dunn, G.H.⁴

22
- 0032423228
- Predictive performance of ten equations for estimating creatinine clearance in cardiac patients
- (1998) Ann Pharmacother , vol.32 , pp. 1275
- Spinler, S.A.¹ Nawarskas, J.J.² Boyce, E.G.³ Connors, J.E.⁴ Charland, S.L.⁵ Goldfarb, S.⁶

23
- 0035028775
- Monitoring renal function in obese patients with type 2 diabetes mellitus in daily practice
- (2001) Diabetes Nutr Metab , vol.14 , pp. 66
- Van de Ree, M.A.¹ Christiaan, G.² Huisman, M.V.³ Van der Vijver, J.C.M.⁴ Meinders, A.E.⁵

24
- 0034254283
- Chemistry, pharmacology and pharmacokinetics of N,N′,N″-triethylenethiophosphoramide (thiotepa)
- (2000) Cancer Treat Rev , vol.26 , pp. 257
- Van Maanen, M.J.¹ Smeets, C.J.M.² Beijnen, J.H.³

25
- 0029921559
- Pharmacokinetics and pharmacodynamics of carboplatin administered in a high-dose combination regimen with thiotepa, cyclophosphamide and peripheral stem cell support
- (1996) Br J Cancer , vol.73 , pp. 979
- Van Warmerdam, L.J.C.¹ Rodenhuis, S.² Van der Wall, E.³ Maes, M.A.⁴ Beijnen, J.H.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.